[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_1500 

# __Limited efficacy against specific viruses__

## Articles mentionning the risk

* [A Continuously Active Antimicrobial Coating effective against Human Coronavirus 229E](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_246.md)

## Category to which it belongs

* [Standardizing coronavirus knowledge, the respiratory virus spreads through the built environment, work, touch, aerosols, and contaminated surfaces.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_73.md)

## Closest similar item

* [Emerging variants of viruses](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_654.md)
* [Exposure to virus](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_610.md)
* [High population density increases virus transmission risk](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2783.md)
* [Increased risk of virus transmission](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1169.md)
* [Insensitive to variations in viral species](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3385.md)
* [Limited availability and effectiveness of antiviral treatments](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1032.md)
* [Preventing virus propagation](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_279.md)
* [Spread of virus](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2484.md)
* [Virus propagation](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3094.md)
* [Virus propagation risks](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_604.md)

## Description of the risk

Antiviral technologies such as surface coatings may not be effective against certain viruses, reducing their ability to prevent infection transmission.

## Is the risk affecting GBN scales

* [No](https://github.com/mm80843/T3.5/blob/pages/ISO_Scale/PBN__ISO_Scale_0.md)

## Mitigations of this risk

* [Research and development of antiviral technologies that are effective against a wider range of viruses.](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_2035.md)

## Name of the risk

Persistence of specific viruses and increased risk of infection transmission.

## People affected by this risk

* [Occupants of commercial and healthcare facilities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_969.md)
* [Residents of residential environments](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_970.md)

## Stakeholders who can mitigate this risk

* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)
* [Technology developers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_761.md)

## Technologies linked to the risk

* [Advanced antiviral technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_790.md)
* [Surface coatings](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_791.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

## Type of impact of the risk (according to ISO37100)

* [Health and care](https://github.com/mm80843/T3.5/blob/pages/ISO_Purpose/PBN__ISO_Purpose_0.md)

## Type of purpose of the risk (according to ISO37100)

* [Safety and security](https://github.com/mm80843/T3.5/blob/pages/ISO_Impact/PBN__ISO_Impact_0.md)

## Type of the risk

* [Physical](https://github.com/mm80843/T3.5/blob/pages/RiskHealth/PBN__RiskHealth_0.md)

## Property: has_RiskType

* [Technological](https://github.com/mm80843/T3.5/blob/pages/RiskType/PBN__RiskType_5.md)

